Global CRISPR/Cas9 Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 135 pages | ID: GE32ACBB024GEN
GlobalInfoResearch

Abstracts

CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.

SCOPE OF THE REPORT:

The global CRISPR/Cas9 market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CRISPR/Cas9.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the CRISPR/Cas9 market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CRISPR/Cas9 market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Caribou Biosciences
• Integrated DNA Technologies (IDT)
• CRISPR Therapeutics
• Merck
• Mirus Bio
• Editas Medicine
• Takara Bio
• Thermo Fisher Scientific
• Horizon Discovery Group
• Intellia Therapeutics
• Agilent Technologies
• Cellecta
• GenScript
• GeneCopoeia
• Synthego

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Genome Editing
• Genetic engineering
• gRNA Database/Gene Librar
• CRISPR Plasmid
• Human Stem Cells
• Genetically Modified Organisms/Crops
• Cell Line Engineering

Market Segment by Applications, can be divided into

• Biotechnology Companies
• Pharmaceutical Companies
• Academic Institutes
• Research and Development Institutes

Contents

1 CRISPR/CAS9 MARKET OVERVIEW

1.1 Product Overview and Scope of CRISPR/Cas9
1.2 Classification of CRISPR/Cas9 by Types
  1.2.1 Global CRISPR/Cas9 Revenue Comparison by Types (2017-2023)
  1.2.2 Global CRISPR/Cas9 Revenue Market Share by Types in 2017
  1.2.3 Genome Editing
  1.2.4 Genetic engineering
  1.2.5 gRNA Database/Gene Librar
  1.2.6 CRISPR Plasmid
  1.2.7 Human Stem Cells
  1.2.8 Genetically Modified Organisms/Crops
  1.2.9 Cell Line Engineering
1.3 Global CRISPR/Cas9 Market by Application
  1.3.1 Global CRISPR/Cas9 Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Biotechnology Companies
  1.3.3 Pharmaceutical Companies
  1.3.4 Academic Institutes
  1.3.5 Research and Development Institutes
1.4 Global CRISPR/Cas9 Market by Regions
  1.4.1 Global CRISPR/Cas9 Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) CRISPR/Cas9 Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) CRISPR/Cas9 Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CRISPR/Cas9 Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) CRISPR/Cas9 Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CRISPR/Cas9 Status and Prospect (2013-2023)
1.5 Global Market Size of CRISPR/Cas9 (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Caribou Biosciences
  2.1.1 Business Overview
  2.1.2 CRISPR/Cas9 Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Caribou Biosciences CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.2 Integrated DNA Technologies (IDT)
  2.2.1 Business Overview
  2.2.2 CRISPR/Cas9 Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Integrated DNA Technologies (IDT) CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.3 CRISPR Therapeutics
  2.3.1 Business Overview
  2.3.2 CRISPR/Cas9 Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 CRISPR Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
  2.4.1 Business Overview
  2.4.2 CRISPR/Cas9 Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Merck CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mirus Bio
  2.5.1 Business Overview
  2.5.2 CRISPR/Cas9 Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Mirus Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.6 Editas Medicine
  2.6.1 Business Overview
  2.6.2 CRISPR/Cas9 Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Editas Medicine CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.7 Takara Bio
  2.7.1 Business Overview
  2.7.2 CRISPR/Cas9 Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Takara Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.8 Thermo Fisher Scientific
  2.8.1 Business Overview
  2.8.2 CRISPR/Cas9 Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Thermo Fisher Scientific CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.9 Horizon Discovery Group
  2.9.1 Business Overview
  2.9.2 CRISPR/Cas9 Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Horizon Discovery Group CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.10 Intellia Therapeutics
  2.10.1 Business Overview
  2.10.2 CRISPR/Cas9 Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Intellia Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.11 Agilent Technologies
  2.11.1 Business Overview
  2.11.2 CRISPR/Cas9 Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Agilent Technologies CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.12 Cellecta
  2.12.1 Business Overview
  2.12.2 CRISPR/Cas9 Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Cellecta CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.13 GenScript
  2.13.1 Business Overview
  2.13.2 CRISPR/Cas9 Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 GenScript CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.14 GeneCopoeia
  2.14.1 Business Overview
  2.14.2 CRISPR/Cas9 Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 GeneCopoeia CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
2.15 Synthego
  2.15.1 Business Overview
  2.15.2 CRISPR/Cas9 Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Synthego CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CRISPR/CAS9 MARKET COMPETITION, BY PLAYERS

3.1 Global CRISPR/Cas9 Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 CRISPR/Cas9 Players Market Share
  3.2.2 Top 10 CRISPR/Cas9 Players Market Share
3.3 Market Competition Trend

4 GLOBAL CRISPR/CAS9 MARKET SIZE BY REGIONS

4.1 Global CRISPR/Cas9 Revenue and Market Share by Regions
4.2 North America CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
4.3 Europe CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
4.5 South America CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa CRISPR/Cas9 Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CRISPR/CAS9 REVENUE BY COUNTRIES

5.1 North America CRISPR/Cas9 Revenue by Countries (2013-2018)
5.2 USA CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
5.3 Canada CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
5.4 Mexico CRISPR/Cas9 Revenue and Growth Rate (2013-2018)

6 EUROPE CRISPR/CAS9 REVENUE BY COUNTRIES

6.1 Europe CRISPR/Cas9 Revenue by Countries (2013-2018)
6.2 Germany CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
6.3 UK CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
6.4 France CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
6.5 Russia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
6.6 Italy CRISPR/Cas9 Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC CRISPR/CAS9 REVENUE BY COUNTRIES

7.1 Asia-Pacific CRISPR/Cas9 Revenue by Countries (2013-2018)
7.2 China CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
7.3 Japan CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
7.4 Korea CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
7.5 India CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA CRISPR/CAS9 REVENUE BY COUNTRIES

8.1 South America CRISPR/Cas9 Revenue by Countries (2013-2018)
8.2 Brazil CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
8.3 Argentina CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
8.4 Colombia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE CRISPR/CAS9 BY COUNTRIES

9.1 Middle East and Africa CRISPR/Cas9 Revenue by Countries (2013-2018)
9.2 Saudi Arabia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
9.3 UAE CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
9.4 Egypt CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
9.5 Nigeria CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
9.6 South Africa CRISPR/Cas9 Revenue and Growth Rate (2013-2018)

10 GLOBAL CRISPR/CAS9 MARKET SEGMENT BY TYPE

10.1 Global CRISPR/Cas9 Revenue and Market Share by Type (2013-2018)
10.2 Global CRISPR/Cas9 Market Forecast by Type (2018-2023)
10.3 Genome Editing Revenue Growth Rate (2013-2023)
10.4 Genetic engineering Revenue Growth Rate (2013-2023)
10.5 gRNA Database/Gene Librar Revenue Growth Rate (2013-2023)
10.6 CRISPR Plasmid Revenue Growth Rate (2013-2023)
10.7 Human Stem Cells Revenue Growth Rate (2013-2023)
10.8 Genetically Modified Organisms/Crops Revenue Growth Rate (2013-2023)
10.9 Cell Line Engineering Revenue Growth Rate (2013-2023)

11 GLOBAL CRISPR/CAS9 MARKET SEGMENT BY APPLICATION

11.1 Global CRISPR/Cas9 Revenue Market Share by Application (2013-2018)
11.2 CRISPR/Cas9 Market Forecast by Application (2018-2023)
11.3 Biotechnology Companies Revenue Growth (2013-2018)
11.4 Pharmaceutical Companies Revenue Growth (2013-2018)
11.5 Academic Institutes Revenue Growth (2013-2018)
11.6 Research and Development Institutes Revenue Growth (2013-2018)

12 GLOBAL CRISPR/CAS9 MARKET SIZE FORECAST (2018-2023)

12.1 Global CRISPR/Cas9 Market Size Forecast (2018-2023)
12.2 Global CRISPR/Cas9 Market Forecast by Regions (2018-2023)
12.3 North America CRISPR/Cas9 Revenue Market Forecast (2018-2023)
12.4 Europe CRISPR/Cas9 Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific CRISPR/Cas9 Revenue Market Forecast (2018-2023)
12.6 South America CRISPR/Cas9 Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa CRISPR/Cas9 Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure CRISPR/Cas9 Picture
Table Product Specifications of CRISPR/Cas9
Table Global CRISPR/Cas9 and Revenue (Million USD) Market Split by Product Type
Figure Global CRISPR/Cas9 Revenue Market Share by Types in 2017
Figure Genome Editing Picture
Figure Genetic engineering Picture
Figure gRNA Database/Gene Librar Picture
Figure CRISPR Plasmid Picture
Figure Human Stem Cells Picture
Figure Genetically Modified Organisms/Crops Picture
Figure Cell Line Engineering Picture
Table Global CRISPR/Cas9 Revenue (Million USD) by Application (2013-2023)
Figure CRISPR/Cas9 Revenue Market Share by Applications in 2017
Figure Biotechnology Companies Picture
Figure Pharmaceutical Companies Picture
Figure Academic Institutes Picture
Figure Research and Development Institutes Picture
Table Global Market CRISPR/Cas9 Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2013-2023)
Table Caribou Biosciences Basic Information, Manufacturing Base and Competitors
Table Caribou Biosciences CRISPR/Cas9 Type and Applications
Table Caribou Biosciences CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Integrated DNA Technologies (IDT) Basic Information, Manufacturing Base and Competitors
Table Integrated DNA Technologies (IDT) CRISPR/Cas9 Type and Applications
Table Integrated DNA Technologies (IDT) CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table CRISPR Therapeutics CRISPR/Cas9 Type and Applications
Table CRISPR Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck CRISPR/Cas9 Type and Applications
Table Merck CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Mirus Bio Basic Information, Manufacturing Base and Competitors
Table Mirus Bio CRISPR/Cas9 Type and Applications
Table Mirus Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Editas Medicine Basic Information, Manufacturing Base and Competitors
Table Editas Medicine CRISPR/Cas9 Type and Applications
Table Editas Medicine CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Takara Bio Basic Information, Manufacturing Base and Competitors
Table Takara Bio CRISPR/Cas9 Type and Applications
Table Takara Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific CRISPR/Cas9 Type and Applications
Table Thermo Fisher Scientific CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Horizon Discovery Group Basic Information, Manufacturing Base and Competitors
Table Horizon Discovery Group CRISPR/Cas9 Type and Applications
Table Horizon Discovery Group CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Intellia Therapeutics Basic Information, Manufacturing Base and Competitors
Table Intellia Therapeutics CRISPR/Cas9 Type and Applications
Table Intellia Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies CRISPR/Cas9 Type and Applications
Table Agilent Technologies CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Cellecta Basic Information, Manufacturing Base and Competitors
Table Cellecta CRISPR/Cas9 Type and Applications
Table Cellecta CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table GenScript Basic Information, Manufacturing Base and Competitors
Table GenScript CRISPR/Cas9 Type and Applications
Table GenScript CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table GeneCopoeia Basic Information, Manufacturing Base and Competitors
Table GeneCopoeia CRISPR/Cas9 Type and Applications
Table GeneCopoeia CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Synthego Basic Information, Manufacturing Base and Competitors
Table Synthego CRISPR/Cas9 Type and Applications
Table Synthego CRISPR/Cas9 Revenue, Gross Margin and Market Share (2016-2017)
Table Global CRISPR/Cas9 Revenue (Million USD) by Players (2013-2018)
Table Global CRISPR/Cas9 Revenue Share by Players (2013-2018)
Figure Global CRISPR/Cas9 Revenue Share by Players in 2016
Figure Global CRISPR/Cas9 Revenue Share by Players in 2017
Figure Global Top 5 Players CRISPR/Cas9 Revenue Market Share in 2017
Figure Global Top 10 Players CRISPR/Cas9 Revenue Market Share in 2017
Figure Global CRISPR/Cas9 Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global CRISPR/Cas9 Revenue (Million USD) by Regions (2013-2018)
Table Global CRISPR/Cas9 Revenue Market Share by Regions (2013-2018)
Figure Global CRISPR/Cas9 Revenue Market Share by Regions (2013-2018)
Figure Global CRISPR/Cas9 Revenue Market Share by Regions in 2017
Figure North America CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Europe CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure South America CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Table North America CRISPR/Cas9 Revenue by Countries (2013-2018)
Table North America CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure North America CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure North America CRISPR/Cas9 Revenue Market Share by Countries in 2017
Figure USA CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Canada CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Mexico CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Table Europe CRISPR/Cas9 Revenue (Million USD) by Countries (2013-2018)
Figure Europe CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure Europe CRISPR/Cas9 Revenue Market Share by Countries in 2017
Figure Germany CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure UK CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure France CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Russia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Italy CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Table Asia-Pacific CRISPR/Cas9 Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific CRISPR/Cas9 Revenue Market Share by Countries in 2017
Figure China CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Japan CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Korea CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure India CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Southeast Asia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Table South America CRISPR/Cas9 Revenue by Countries (2013-2018)
Table South America CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure South America CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure South America CRISPR/Cas9 Revenue Market Share by Countries in 2017
Figure Brazil CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Argentina CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Colombia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Table Middle East and Africa CRISPR/Cas9 Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CRISPR/Cas9 Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa CRISPR/Cas9 Revenue Market Share by Countries in 2017
Figure Saudi Arabia CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure UAE CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Egypt CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure Nigeria CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Figure South Africa CRISPR/Cas9 Revenue and Growth Rate (2013-2018)
Table Global CRISPR/Cas9 Revenue (Million USD) by Type (2013-2018)
Table Global CRISPR/Cas9 Revenue Share by Type (2013-2018)
Figure Global CRISPR/Cas9 Revenue Share by Type (2013-2018)
Figure Global CRISPR/Cas9 Revenue Share by Type in 2017
Table Global CRISPR/Cas9 Revenue Forecast by Type (2018-2023)
Figure Global CRISPR/Cas9 Market Share Forecast by Type (2018-2023)
Figure Global Genome Editing Revenue Growth Rate (2013-2018)
Figure Global Genetic engineering Revenue Growth Rate (2013-2018)
Figure Global gRNA Database/Gene Librar Revenue Growth Rate (2013-2018)
Figure Global CRISPR Plasmid Revenue Growth Rate (2013-2018)
Figure Global Human Stem Cells Revenue Growth Rate (2013-2018)
Figure Global Genetically Modified Organisms/Crops Revenue Growth Rate (2013-2018)
Figure Global Cell Line Engineering Revenue Growth Rate (2013-2018)
Table Global CRISPR/Cas9 Revenue by Application (2013-2018)
Table Global CRISPR/Cas9 Revenue Share by Application (2013-2018)
Figure Global CRISPR/Cas9 Revenue Share by Application (2013-2018)
Figure Global CRISPR/Cas9 Revenue Share by Application in 2017
Table Global CRISPR/Cas9 Revenue Forecast by Application (2018-2023)
Figure Global CRISPR/Cas9 Market Share Forecast by Application (2018-2023)
Figure Global Biotechnology Companies Revenue Growth Rate (2013-2018)
Figure Global Pharmaceutical Companies Revenue Growth Rate (2013-2018)
Figure Global Academic Institutes Revenue Growth Rate (2013-2018)
Figure Global Research and Development Institutes Revenue Growth Rate (2013-2018)
Figure Global CRISPR/Cas9 Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global CRISPR/Cas9 Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global CRISPR/Cas9 Revenue Market Share Forecast by Regions (2018-2023)
Figure North America CRISPR/Cas9 Revenue Market Forecast (2018-2023)
Figure Europe CRISPR/Cas9 Revenue Market Forecast (2018-2023)
Figure Asia-Pacific CRISPR/Cas9 Revenue Market Forecast (2018-2023)
Figure South America CRISPR/Cas9 Revenue Market Forecast (2018-2023)
Figure Middle East and Africa CRISPR/Cas9 Revenue Market Forecast (2018-2023)